These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 29033481)
1. Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India. Mukherjee S; Era N; Saha B; Tripathi SK Indian J Pharmacol; 2017; 49(3):223-228. PubMed ID: 29033481 [TBL] [Abstract][Full Text] [Related]
2. Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study. Nagpal M; Tayal V; Kumar S; Gupta U Indian J Med Sci; 2010 Jun; 64(6):245-52. PubMed ID: 22885315 [TBL] [Abstract][Full Text] [Related]
3. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India. Modayil RR; Harugeri A; Parthasarathi G; Ramesh M; Prasad R; Naik V; Giriyapura V Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):247-55. PubMed ID: 20066675 [TBL] [Abstract][Full Text] [Related]
4. HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India. Anwikar SR; Bandekar MS; Smrati B; Pazare AP; Tatke PA; Kshirsagar NA Int J Risk Saf Med; 2011; 23(3):163-9. PubMed ID: 22020396 [TBL] [Abstract][Full Text] [Related]
5. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. Geer MI; Koul PA; Tanki SA; Shah MY J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493 [TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. Eluwa GI; Badru T; Agu KA; Akpoigbe KJ; Chabikuli O; Hamelmann C BMC Clin Pharmacol; 2012 Feb; 12():7. PubMed ID: 22369677 [TBL] [Abstract][Full Text] [Related]
7. Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua. Lorío M; Colasanti J; Moreira S; Gutierrez G; Quant C J Int Assoc Provid AIDS Care; 2014; 13(5):466-70. PubMed ID: 24935691 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral Therapy-associated Adverse Drug Reactions and their Effects on Virologic Failure- A Retrospective Cohort Study in Nigeria. Abah IO; Ncube NBQ; Bradley HA; AgbaJi OO; Kanki P Curr HIV Res; 2018; 16(6):436-446. PubMed ID: 30767743 [TBL] [Abstract][Full Text] [Related]
9. Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati. Rukmangathen R; Brahmanapalli VD; Thammisetty DP; Pemmasani D; Gali SD; Atmakuru RB Perspect Clin Res; 2020; 11(4):158-163. PubMed ID: 33489833 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients. Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298 [TBL] [Abstract][Full Text] [Related]
11. Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus. Setkina S; Dotsenko M; Bondar S; Charnysh I; Kuchko A; Kaznacheeva A; Kozorez E; Dodaleva A; Rossa N Drug Saf; 2015 Apr; 38(4):365-72. PubMed ID: 25808626 [TBL] [Abstract][Full Text] [Related]
12. Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India. Shet A; Antony J; Arumugam K; Kumar Dodderi S; Rodrigues R; DeCosta A PLoS One; 2014; 9(3):e91028. PubMed ID: 24614165 [TBL] [Abstract][Full Text] [Related]
13. Incidence of atazanavir- associated adverse drug reactions in second -line drugs treated south Indian HIV-1 infected patients. Subashini D; Dinesha TR; Boobalan J; Samuel LC; Poongulali S; Pradeep A; Solomon SS; Solomon S; Balakrishnan P; Saravanan S Indian J Pharmacol; 2016; 48(5):582-585. PubMed ID: 27721547 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran. Koochak HE; Babaii A; Pourdast A; Golrokhy R; Rasoolinejad M; Khodaei S; Moghadam SRJ; Taheri RR; Seyed Alinaghi SA Infect Disord Drug Targets; 2017; 17(2):116-119. PubMed ID: 28164754 [TBL] [Abstract][Full Text] [Related]
15. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]
16. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria. Popoola TD; Awodele O; Oshikoya KA Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy. Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397 [TBL] [Abstract][Full Text] [Related]
18. Adverse Drug Reactions and Prescription Patterns of Antiretroviral Drugs: A Longitudinal Observational Study From a Tertiary Care Hospital in Western India. Sekar VD; Joshi K; Bhide S; Rao S; Phirke C; Patil S; Kothari R; Patel M; Shankar A Cureus; 2024 Mar; 16(3):e56424. PubMed ID: 38638708 [TBL] [Abstract][Full Text] [Related]
19. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study. Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890 [TBL] [Abstract][Full Text] [Related]
20. Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia. Bezabhe WM; Bereznicki LR; Chalmers L; Gee P; Kassie DM; Bimirew MA; Peterson GM Drug Saf; 2015 Jul; 38(7):629-39. PubMed ID: 26008986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]